Molecular properties of lysine dendrimers and their interactions with aβ-peptides and neuronal cells

Current Medicinal Chemistry

Volumn 20, Issue 1, 2013, Pages 134-143

  Neelov, I M ^a,d   Janaszewska, A ^b   Klajnert, B ^b   Bryszewska, M ^b   Makova, N Z ^c   Hicks, D ^c   Pearson, H A ^c   Vlasov, G P ^d   Ilyash, M Yu ^d   Vasilev, D S ^e   Dubrovskaya, N M ^e   Tumanova, N L ^e   Zhuravin, I A ^e   Turner, A J ^c   Nalivaeva, N N ^c,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d INSTITUTE OF MACROMOLECULAR COMPOUNDS   (Russian Federation)

^e SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Amyloid (A ) peptide; Amyloidogenesis; Cell viability; Computer simulation; Dendrimers; Patch clamp; Polylysine dendrimers; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN; DENDRIMER; POLYLYSINE; POLYLYSINE DENDRIMER D3; POLYLYSINE DENDRIMER D5; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ARTICLE; BRAIN REGION; CELL VIABILITY; CELLULAR DISTRIBUTION; COMPUTER SIMULATION; CYTOTOXICITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; PATCH CLAMP; PROTEIN AGGREGATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELL LINE; CELL SURVIVAL; DENDRIMERS; HUMANS; MODELS, MOLECULAR; NEURONS; PATCH-CLAMP TECHNIQUES; POLYLYSINE; RATS;

EID: 84872955388     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673130113     Document Type: Article

References (47)

1. Buhleier, E.; Wehner, W.; Vögtle, F. Cascade and Nonskid-chain-like Synthesis of Molecular Cavity Topologies. Synthesis, 1978, 2, 155-158.
2. Denkewalter, R.G.; Kolc, J.; Lukasavage, W. J. Macromolecular highly branched homogeneous compound based on lysine units. M.S. Patent 4,289,872, 1981.
3. Tomalia, D.A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. A new class of polymers: starburst-dendritic macromolecules. Polym. J., 1985, 17(1), 117-132.
4. Tam, J. P. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. M.S.A., 1988, 85(15), 5409-5413.
5. Vlasov, G.P.; Korol'kov, V.I.; Pankova, G.A.; Tarasenko, I.I.; Baranov, A.N.; Glazkov, P.B.; Kiselev, A.V.; Ostapenko, O.V.; Lesina, E.A.; Baranov, V.S. Lysine dendrimers and their starburst polymer derivatives: possible application for DNA compaction and in vitro delivery of genetic constructs. Russian J. Bioorg. Chem., 2004, 30, 12-20.
6. Janiszewska, J.; Urbaczyk-Lipkowska, Z. Synthesis, antimicrobial activity and structural studies of low molecular mass lysine dendrimers. Acta Biochim. Pol., 2006, 53, 77-82.
7. Westermark, G.T.; Westermark, P. Prion-like aggregates: infectious agents in human disease. Trends Mol. Med., 2010, 16(11), 501-507.
8. Hardy, J.A.; Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256(5054), 184-185.
9. Larson, M.E.; Lesné, S.E. Soluble Aoligomer production and toxicity. J. Neurochem., 2012; 120(Suppl. 1), 125-139.
10. Klajnert, B.; Cladera, J.; Bryszewska, M. Molecular interactions of dendrimers with amyloid peptides: pH dependence. Biomacromolecules, 2006, 7, 2186-2191.
11. Klajnert, B.; Cangiotti, M.; Calici, S.; Majoral, J.P.; Caminade, A. M.; Cladera, J.; Bryszewska, M.; Ottaviani, M.F. EPR Study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases, Macromol. Biosci., 2007, 7, 1065-1074.
12. Wasiak, T.; Ionov, M.; Nieznanski, K.; Nieznanska, H.; Klementieva, O.; Granell, M.; Cladera, J.; Majoral, J.P.; Caminade, P.A.; Klajnert, B. Phosphorus Dendrimers Affect Alzheimer's (A1-28) Peptide and MAP-Tau Protein Aggregation. Mol. Pharm., 2012, 9(3), 458-469.
13. Vlasov, G.P.; Pavlov, G.M.; Bayanova, N.V.; Korneeva, E.V.; Ebel, C.; Khodorkovskii, M.A.; Artamonova T.O. Dendrimers based on -amino acids: synthesis and hydrodynamic characteristics Doklady Physical Chemistry, 2004, 399, 290-292.
14. Vlasov, G.P.; Tarasenko, I.I.; Valueva, S.V.; Kipper, A.I.; Tarabukina, E.B.; Filippov, A.P.; Avdeeva, E.V.; Vorob'ev, V.I. Hyperbranched poly(L-lysine) containing additional amino acids or their oligomers between branching points: synthesis and structure. Polymer Science, Ser. A, 2005, 47(5), 422-429.
15. Wang, J.; Cieplak, P.; Kollman, P.A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem., 2000, 21(12), 1049-1074.
16. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald-an NlogN method for Ewald sums in large systems. J. Chem. Phys., 1993, 98, 10089-10092.
17. Hess, B.; Kutzner, C.; Van der Spoel, D.; Lindahl, E.J. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput., 2008, 4, 435-447.
18. Mosmann, T. Rapid colorimetric assay for growth and survival: Application to proliferation and cytotoxicity assay. J. Immunol. Meth., 1983, 65, 55-63.
19. Klajnert, B.; Cortijo-Arellano, M.; Cladera, J.; Majoral, J.P.; Caminade, A.M.; Bryszewska, M. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208. Biochem. Biophys. Res. Commun., 2007, 364(1), 20-25.
20. Plant, L.D.; Boyle, J.P.; Thomas, N.M.; Hipkins, N.J.; Benedikz, E.;, Hooper, N.M.; Henderson, Z.; Vaughan, P.F.; Peers, C.; Cowburn, R.F.; Pearson, H.A. Presenilin-1 mutations alter K+ currents in the human neuroblastoma cell line, SH-SY5Y. Neuroreport, 2002, 13(12), 1553-1556.
21. Paxinos, G.; Watson, C. The Rat brain in stereotaxic coordinates. 4th edition. Academic Press, San Diego, 1998.
22. Kerrigan, T.L.; Atkinson, L.; Peers, C.; Pearson, H.A. Modulation of 'A'-type K+ current by rodent and human forms of amyloid beta protein. Neuroreport, 2008, 19(8), 839-843.
23. Plant, L.D.; Webster, N.J.; Boyle, J.P.; Ramsden, M.; Freir, D.B.; Peers, C.; Pearson, H.A. Amyloid peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiol. Aging, 2006, 27(11), 1673-1683.
24. Ramsden, M.; Plant, L.D.; Webster, N.J.; Vaughan, P.F.; Henderson, Z.; Pearson, H.A. Differential effects of unaggregated and aggregated amyloid protein (1-40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones. J. Neurochem., 2001, 79(3), 699-712.
25. De Gennes, P.G.; Hervet, H. Statistics of starburst polymers. J. Phys. Lett., 1983, 44, L351-360.
26. Lescanec, R.L.; Muthukumar, M. Configurational characteristics and scaling behavior of starburst molecules: a computational study. Macromolecules, 1990, 23(8), 2280-2288.
27. Mansfield, M.L.; Klushin, L.I. Intrinsic viscosity of model sturburst dendrimers. J. Phys. Chem., 1992, 96(10), 3994-3998.
28. Murat, M.; Grest, G.S. Molecular dynamics study of dendrimer molecules in solvents of varying quality. Macromolecules, 1996, 29, 1278-1285.
29. Lyulin, A.V.; Davies, G.R.; Adolf, D.B. Location of the terminal groups of dendrimers: Brownian dynamic simulation, Macromolecules, 2000, 33(18), 6899-6900.
30. Cagin, T.; Wang, G.; Martin, r.; Goddard, W.A. Molecular modeling of dendrimers for nanoscale applications. Nanotechnology, 2000, 11(2), 77-84.
31. Neelov, I.M.; Adolf, D.B. Brownian dynamics simulations of dendrimers under elongational flow: bead-rod model with hydrodynamic interactions. Macromolecules, 2003, 36, 6914-6924.
32. Mazo, M.; Shamaev, M.; Balabaev, N.; Darinskii, A.; Neelov, I. Conformational mobility of carbosilane dendrimer: molecular dynamics simulation. Phys. Chem. Chem. Phys., 2004, 6(6), 1285-1289.
33. Cattani-Scholz, A.; Renner, C.; Oesterhelt, D.; Moroder, L. Photoresponsive dendritic azobenzene peptides. Chem-BioChem., 2001, 2, 542-549.
34. al-Jamal, K. T.; Sakthivel, T.; Florence, A. T. Dendrisomes: cationic lipidic dendron vesicular assemblies. Int. J. Pharm., 2003, 254, 33-36.
35. Arai, T.; Ogawa, J.; Mouri, E.; Bhuiyan, M. P. I.; Nishino, N. Formation of submicron scale particles of narrow size distribution from a water-soluble dendrimer with links to porphyrins and a fullerene. Macromolecules, 2006, 39, 1607-1613.
36. Roberts, B.P.; Scanlon, M.J.; Krippner, G.Y.; Chalmers, D.K. Molecular dynamics of poly(L-lysine) dendrimers with naphthalene disulfonate caps. Macromolecules, 2009, 42, 2775-2783.
37. Roberts, B.P.; Krippner, G.Y.; Scanlon, M.J.; Chalmers, D.K. Molecular dynamics of variegated polyamide dendrimers. Macromolecules, 2009, 42, 2784-2794.
38. Miyano, T.; Wijagkanalan, W.; Kawakami, S.; Yamashita, F.; Hashida, M. Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells. Mol. Pharm., 2010, 7(4), 1318-1327.
39. Janaszewska, A.; Ziemba, B.; Ciepluch, K.; Appelhans, D.; Voit, B.; Klajnert, B.; Bryszewska, M. The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein -proofs of crossing blood-brain-barrier. New J. Chem., 2012, 36, 350-353.
40. Pearson, H.A.; Peers, C. Physiological roles for amyloid peptides. J. Physiol., 2006, 575(1), 5-10.
41. Nalivaeva, N.N.; Beckett, C.; Belyaev, N.D.; Turner, A.J. Are amyloiddegrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem., 2012, 120(Suppl. 1), 167-185.
42. Roberts, B.R.; Ryan, T.M.; Bush, A.I.; Masters, C.L.; Duce, J.A. The role of metallobiology and amyloid-peptides in Alzheimer's disease. J. Neurochem., 2012, 120(Suppl. 1), 149-166.
43. Klajnert, B.; Cortijo-Arellano, M.; Bryszewska, M.; Cladera, J. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases. Biochem. Biophys. Res. Commun., 2006, 339(2), 577-582.
44. Klajnert, B.; Cladera, J.; Bryszewska, M. Molecular interactions of dendrimers with amyloid peptides: pH dependence. Biomacromolecules, 2006, 7(7), 2186-2191.
45. Klementieva, O.; Benseny-Cases, N.; Gella, A.; Appelhans, D.; Voit, B.; Cladera, J. Dense shell glycodendrimers as potential nontoxic antiamyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity. Biomacromolecules, 2011, 12(11), 3903-3909.
46. Walsh, D.M.; Klyubin, I.; Fadeeva, J.V.; Rowan, M.J.;Selkoe, D.J. Amyloid-oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans., 2002, 30(4), 552-557.
47. Demuro, A.; Mina, E.; Kayed, R.; Milton, S.C.; Parker, I.; Glabe, C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem., 2005, 280(17), 17294-17300.